---
title: "RenovoRx Reports 2025 Results and Advances TIGeR-PaC Trial"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281085728.md"
description: "RenovoRx Reports 2025 Results and Advances TIGeR-PaC Trial"
datetime: "2026-03-30T22:52:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281085728.md)
  - [en](https://longbridge.com/en/news/281085728.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281085728.md)
---

# RenovoRx Reports 2025 Results and Advances TIGeR-PaC Trial

RenovoRx Reports 2025 Results and Advances TIGeR-PaC Trial

### Related Stocks

- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [RNXT.US](https://longbridge.com/en/quote/RNXT.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)

## Related News & Research

- [RenovoRx Q1 revenue rises as number of active cancer centers increase](https://longbridge.com/en/news/286462396.md)
- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)
- [NeOnc Advances Glioma Programs and Strengthens Financial Position](https://longbridge.com/en/news/286826865.md)
- [Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call](https://longbridge.com/en/news/286422585.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)